PPLPHARMA.BOPPLPHARMA.BOBSE
Loading
Operating Income Growth Recovery in ProgressRecovering
Percentile Rank61
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P61
Within normal range
vs 2Y Ago
1.4x
Solid growth
Streak
2 qtr
Consecutive growthRecovering
PeriodValue
Q4 202561.47%
Q3 202551.26%
Q2 2025-102.74%
Q1 20252242.87%
Q4 2024-5.66%
Q3 2024649.20%
Q2 2024-94.03%
Q1 2024306.83%
Q4 202344.07%
Q3 2023237.93%
Q2 2023-124.67%
Q1 2023317.04%
Q4 2022-1310.36%
Q3 2022104.41%
Q2 2022-205.23%
Q1 2022-75.40%
Q4 2021854.60%
Q3 2021-89.09%
Q2 20210.00%